Genmab A/S (GNMSF)
316.00
0.00 (0.00%)
USD |
OTCM |
Dec 09, 16:00
Genmab EPS Diluted (Quarterly): 6.46 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novo Nordisk A/S | 0.7044 |
| Ascendis Pharma A/S | -1.173 |
| Evaxion AS | -0.2862 |
| IO Biotech, Inc. | -0.1252 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 401.00M |
| Revenue (Quarterly) | 1.022B |
| Total Expenses (Quarterly) | 621.00M |
| Enterprise Value | 16.20B |
| Gross Profit Margin (Quarterly) | 94.32% |
| Profit Margin (Quarterly) | 39.24% |
| Earnings Yield | 7.44% |
| Operating Earnings Yield | 6.65% |
| Normalized Earnings Yield | 7.474 |